InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.54
(
-0.19%
)
Bitcoin
65,137.27
(
0.26%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: tony111 post# 196582

Friday, 10/30/2015 7:34:22 AM

Friday, October 30, 2015 7:34:22 AM

Post# of 252255

Teva would have got epipen approved long time ago with MNTA's characterization techniques.

Think the difficulty in this case is with the auto-injector delivery device not epinephrine itself. So I don't think Teva would have done better partnering with Momenta than with Antares on generic EpiPen.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up